Breaking News Instant updates and real-time market news.

VEEV

Veeva

$63.85

-0.4 (-0.62%)

, MDSO

Medidata

$81.00

-0.77 (-0.94%)

07:06
07/18/17
07/18
07:06
07/18/17
07:06

Veeva files suit to fight 'unfair business practices that limit employee rights'

Veeva Systems (VEEV) announced it filed a lawsuit in the superior court of California to stop companies' widespread misuse of non-compete, confidentiality, and non-disparagement agreements that restrict employees' basic rights. Clauses in these agreements can materially impact an employee's ability to pursue new job opportunities. Veeva is taking legal action to address the increasing limitations companies are placing on employees. The case can set an important precedent in the enforcement of employment clauses that are illegal in states such as California. Veeva filed suit against three companies, Medidata (MDSO), QuintilesIMS (Q), and Sparta, for using illegal provisions in their employment agreements, including post-termination non-competes and overly broad confidentiality and non-disparagement clauses. All of these provisions make it harder, if not impossible, for employees to change jobs and provide services to California-based employers. The suit asserts that such agreements restrict fair competition and violate California law. Veeva has taken this legal action to protect employees from abusive employment clauses and enable them to freely pursue career opportunities at Veeva. The company competes for employees on the merits of its competitive wages and benefits, work environment, and innovative services and products. It does not require employees to sign non-compete agreements and it will not let a current or past non-compete prevent it from hiring a qualified candidate.

VEEV

Veeva

$63.85

-0.4 (-0.62%)

MDSO

Medidata

$81.00

-0.77 (-0.94%)

Q

QuintilesIMS

$90.08

0.7 (0.78%)

  • 18

    Jul

VEEV Veeva
$63.85

-0.4 (-0.62%)

06/05/17
06/05/17
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Apple (AAPL) downgraded to Sector Weight from Overweight at Pacific Crest with analyst Andy Hargreaves saying upside from the launch of iPhone 8 is already reflected in the shares. An "extremely strong iPhone 8 cycle" is being priced into the stock while little weight is being given to gross margins, supply issues, or the likelihood for declines beyond the iPhone 8, Hargreaves tells investors in a research note. 2. Perrigo (PRGO) downgraded to Underperform from Sector Perform at RBC Capital with analyst Randall Stanicky saying the growth rate of the company's U.S. consumer business "has structurally re-rated lower" amid pricing headwinds and share losses. 3. Endocyte (ECYT) downgraded to Neutral from Outperform at Wedbush and to Market Perform from Outperform at Cowen. 4. Affiliated Managers (AMG) was downgraded to Neutral from Buy at Citi while Federated Investors (FII) was downgraded to Sell from Neutral. 5. Veeva (VEEV) downgraded to Equal Weight from Overweight at Morgan Stanley with the firm's analyst saying the 60%+ move in shares year-to-date captures much of the near-term upside in the stock. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
05/26/17
05/26/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. GlaxoSmithKline (GSK) upgraded to Buy from Hold at Berenberg with analyst Alistair Campbell saying Glaxo's long-term value is emerging and the market underappreciates the strength and breadth of its diversified business. 2. Rayonier Advanced Materials (RYAM) was upgraded to Buy from Hold at Vertical Research and to Buy from Neutral at BofA/Merrill. 3. Red Robin (RRGB) upgraded to Buy from Hold at Canaccord with analyst Lynne Collier citing greater confidence in its top-line drivers and in stable to improving casual dining trends. Collier raised her price target to $90 from $72 on Red Robin shares. 4. Star Bulk Carriers (SBLK) upgraded to Buy on valuation at Seaport Global with analyst Magnus Fyhr citing the pullback in shares and favorable drybulk market fundamentals. Fyhr raised his price target on Star Bulk shares to $13 from $11.50. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/05/17
MSCO
06/05/17
DOWNGRADE
MSCO
Equal Weight
Veeva downgraded to Equal Weight from Overweight at Morgan Stanley
06/05/17
MSCO
06/05/17
DOWNGRADE
Target $68
MSCO
Equal Weight
Veeva downgraded to Equal Weight due to valuation at Morgan Stanley
As previously reported, Morgan Stanley downgraded Veeva to Equal Weight from Overweight and raised its price target to $68 from $53. The analyst said the 60%+ move in shares year-to-date captures much of the near-term upside in the stock. .
MDSO Medidata
$81.00

-0.77 (-0.94%)

06/06/17
BOFA
06/06/17
INITIATION
Target $85
BOFA
Buy
Medidata initiated with a Buy at BofA/Merrill
BofA/Merrill analyst Steven Valiquette initiated Medidata Solutions with a Buy and an $85 price target saying it has established itself as a lading provider of cloud-based clinical trial data capture with robust growth.
06/12/17
KEYB
06/12/17
NO CHANGE
KEYB
Medidata to benefit from growth of risk-based monitoring, says KeyBanc
KeyBanc says that industry guidelines recently adopted by the EU should be a catalyst for risk-based monitoring technologies, or RBM. The firm says that Medidiata is the HCT it covers which is most exposed to RBM. It thinks that the company's revenue from RBM has reached a $50M annual run rate, while further adoption of RBM should accelerate adoption of its other SaaS tools. KeyBanc raised its price target on the stock to $84 from $83 and keeps an Overweight rating on the shares.
05/01/17
JEFF
05/01/17
UPGRADE
Target $63
JEFF
Hold
Medidata upgraded to Hold from Underperform at Jefferies
Jefferies analyst David Windley upgraded Medidata Solutions to Hold citing increased confidence in the company's growth targets. Channel checks suggest competitive displacements and increasing deal size should drive sustained high-teens to 20% revenue growth, the analyst contends. He raised his price target for the shares to $63 from $47.
06/27/17
RHCO
06/27/17
NO CHANGE
RHCO
Medidata price target raised to $90 from $80 at SunTrust
SunTrust analyst Sandy Draper says that inVentiv appears to be pursuing " a much larger relationship" with Medidiata. The analyst adds that Medidata "recently signed one of its first multi-million dollar, multi-year imaging deals" in the wake of its 2Q16 acquisition of Intelmage. Draper raised his price target on Medidata to $90 from $80 and keeps a Buy rating on the stock.
Q QuintilesIMS
$90.08

0.7 (0.78%)

06/21/17
WELS
06/21/17
NO CHANGE
WELS
QuintilesIMS added to Priority Stock List at Wells Fargo
Wells Fargo added QuintilesIMS (Q) to its Priority Stock List and removed ICON plc (ICLR). The firm thinks that QuintilesIMS' EPS can reach about $7 per share in 2020, driven partly by capital deployment and cost synergies. It predicts that the stock's annualized return will come in at 14% over three years. After The Wall Street Journal reported that ICON was bidding for Parexel (PRXL), Wells Fargo is unhappy with the news, saying that the deal would potentially create revenue dis-synergies and that ICON's interest indicates that it might be threatened by rising competition. Wells keeps Outperform ratings on QuintilesIM and ICON.
06/12/17
KEYB
06/12/17
NO CHANGE
KEYB
CROs should benefit from growth of risk-based monitoring, says KeyBanc
KeyBanc says that industry guidelines recently adopted by the EU should be a catalyst for risk-based monitoring technologies, or RBM. KeyBanc says that CROs such as QuintilesIMS (Q) and ICON plc (ICON) can bundle their risk-based monitoring software-as-a-service with their other services, generating efficiencies which can increase their profits. The analyst adds that the increased use of RBM should increase the CROs' gross margins and market share over the longer run. The firm raised its price target on QuintilesIMS to $96 from $90 and on ICON to $103 from $98. It keeps Overweight ratings on QuintilesIMS and ICON.
03/31/17
FBCO
03/31/17
INITIATION
Target $89
FBCO
Outperform
QuintilesIMS initiated with an Outperform at Credit Suisse
Credit Suisse analyst Erin Wilson Wright started QuintilesIMS with an Outperform rating and an $89 price target saying it should benefit from sustained strength in outsourcing demand while leveraging its leading global healthcare information and technology platform.
05/03/17
WELS
05/03/17
DOWNGRADE
WELS
Market Perform
Medpace downgraded to Market Perform from Outperform at Wells Fargo
Wells Fargo analyst Tim Evans downgraded Medpace (MEDP) to Market Perform saying the company has "considerably lower visibility than peers" on 2017 and 2018. The analyst prefers contract research organizations that are most likely to be share takers in an increasingly competitive environment. He lowered his price target range for the shares to $23-$25 from $32-$33. Evans this morning also downgraded INC Research (INCR) to Market Perform. He views PRA Health (PRAH), ICON plc (ICLR) and QuintilesIMS (Q) as share takers in the CRO space.

TODAY'S FREE FLY STORIES

GPC

Genuine Parts

$89.71

-8.33 (-8.50%)

08:27
10/20/17
10/20
08:27
10/20/17
08:27
Recommendations
Genuine Parts analyst commentary  »

Genuine Parts weakness a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Oct

BOJA

Bojangles

$12.50

0.1 (0.81%)

08:26
10/20/17
10/20
08:26
10/20/17
08:26
Downgrade
Bojangles rating change  »

Bojangles downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

TEAM

Atlassian

$40.25

0.44 (1.11%)

08:25
10/20/17
10/20
08:25
10/20/17
08:25
Recommendations
Atlassian analyst commentary  »

Atlassian price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AGN

Allergan

$189.27

2.12 (1.13%)

08:25
10/20/17
10/20
08:25
10/20/17
08:25
Recommendations
Allergan analyst commentary  »

Allergan price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Oct

  • 23

    Oct

  • 01

    Nov

  • 06

    Nov

08:25
10/20/17
10/20
08:25
10/20/17
08:25
General news
Fed funds futures are lower as safe haven flows unwind as risk appetite jumps »

Fed funds futures are…

WBC

Wabco

$155.08

6.01 (4.03%)

08:23
10/20/17
10/20
08:23
10/20/17
08:23
Recommendations
Wabco analyst commentary  »

Wabco price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAL

United Continental

$59.78

-8.21 (-12.08%)

08:22
10/20/17
10/20
08:22
10/20/17
08:22
Recommendations
United Continental analyst commentary  »

Limited visibility keeps…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENBL

Enable Midstream

$15.60

0.06 (0.39%)

08:22
10/20/17
10/20
08:22
10/20/17
08:22
Downgrade
Enable Midstream rating change  »

Enable Midstream…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Nov

$DJT

DJ Transportation Average

08:22
10/20/17
10/20
08:22
10/20/17
08:22
Technical Analysis
DJ Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$DJU

DJ Utility Average

08:21
10/20/17
10/20
08:21
10/20/17
08:21
Technical Analysis
DJ Utility Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DJX

Dow Jones Industrial Average

08:21
10/20/17
10/20
08:21
10/20/17
08:21
Technical Analysis
Dow Jones Industrial Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IYT

iShares Transportation Average

$177.87

-0.23 (-0.13%)

08:21
10/20/17
10/20
08:21
10/20/17
08:21
Technical Analysis
iShares Transportation Average: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLK

Technology Select Sector SPDR

$60.69

-0.18 (-0.30%)

08:20
10/20/17
10/20
08:20
10/20/17
08:20
Technical Analysis
Technology Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLE

Energy Select Sector SPDR

$67.64

-0.21 (-0.31%)

08:20
10/20/17
10/20
08:20
10/20/17
08:20
Technical Analysis
Energy Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLY

Consumer Discretionary Sector SPDR

08:20
10/20/17
10/20
08:20
10/20/17
08:20
Technical Analysis
Consumer Discretionary Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:20
10/20/17
10/20
08:20
10/20/17
08:20
General news
Canada CPI preview »

Canada CPI preview:…

XLB

S&P Select Materials SPDR

$58.24

0.22 (0.38%)

08:19
10/20/17
10/20
08:19
10/20/17
08:19
Technical Analysis
S&P Select Materials SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLU

Utilities SPDR

$54.82

0.57 (1.05%)

08:19
10/20/17
10/20
08:19
10/20/17
08:19
Technical Analysis
Utilities SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLP

Consumer Staples Sector SPDR

$54.03

-0.29 (-0.53%)

08:19
10/20/17
10/20
08:19
10/20/17
08:19
Technical Analysis
Consumer Staples Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SKX

Skechers

$24.03

-1.06 (-4.22%)

08:18
10/20/17
10/20
08:18
10/20/17
08:18
Recommendations
Skechers analyst commentary  »

Evercore ISI initiates a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XLV

Health Care Select Sector SPDR

$83.79

0.51 (0.61%)

08:18
10/20/17
10/20
08:18
10/20/17
08:18
Technical Analysis
Health Care Select Sector SPDR: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IWM

iShares Trust Russell 2000 Index Fund

$149.29

-0.23 (-0.15%)

08:18
10/20/17
10/20
08:18
10/20/17
08:18
Technical Analysis
iShares Trust Russell 2000 Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QURE

uniQure

$15.16

5.69 (60.08%)

08:18
10/20/17
10/20
08:18
10/20/17
08:18
Technical Analysis
Technical View: uniQure hits fresh 52-week highs, levels to watch »

The stock is up over…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DIA

Diamonds Fund ETF

$231.47

0.19 (0.08%)

08:18
10/20/17
10/20
08:18
10/20/17
08:18
Technical Analysis
Diamonds Fund ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPY

SPDR S&P 500 ETF Trust

$255.79

0.07 (0.03%)

08:17
10/20/17
10/20
08:17
10/20/17
08:17
Technical Analysis
SPDR S&P 500 ETF Trust: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.